The $9 billion agreed merger of Quintiles Transnational Holdings Inc and IMS Health Holdings Inc is the latest, and one of the most ambitious, attempts by industry to use advances in information technology to bring down the cost of drug development. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
